The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is enclosed.

ALPA LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

The Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required

The Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.

Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.

Alpa Laboratories Limited has informed the Exchange regarding Board meeting held on February 13, 2024.

Alpa Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 13, 2024.

Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.

Alpa Laboratories Limited has informed the Exchange regarding Board meeting held on February 13, 2024.

Alpa Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 13, 2024.

ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .

ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015